1 BTC
=
- USD
Intra-Cellular Therapies Inc.
As of May 30, 2026 at 24:05 UTC
Chart
About Intra-Cellular Therapies Inc.
No description available.
Market Statistics
Trading Metrics
How to Buy ITCI
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy ITCI
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articles
Intra-Cellular Therapies reported strong financial results for Q4 2024, with CAPLYTA net product sales growing 51% year-over-year. The company also announced the FDA's acceptance of a supplemental New Drug Application for CAPLYTA as an adjunctive treatment for major depressive disorder.
Johnson & Johnson announced plans to acquire Intra-Cellular Therapies for $14.6 billion, which could bolster its pipeline and strengthen its neurological business. However, the acquisition is unlikely to turn Johnson & Johnson into a high-growth stock, as its growth rate is expected to remain in the single digits.
The chronic pain clinical trial pipeline is experiencing momentum, with over 20 companies working on 25+ pipeline drugs. Key companies like Apurano Pharmaceuticals, Centrexion Therapeutics, and Neumentum are evaluating promising therapies to improve the treatment landscape.
